N -Formyl hydroxylamine containing dipeptides: generation of a new class of vasopeptidase inhibitors
- 22 February 2000
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 10 (3) , 257-260
- https://doi.org/10.1016/s0960-894x(99)00671-x
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Sustained antihypertensive actions of a dual angiotensin-converting enzyme neutral endopeptidase inhibitor, sampatrilat, in black hypertensive subjectsAmerican Journal of Hypertension, 1999
- OmapatrilatDrugs of the Future, 1999
- Inhibition stereochemistry of hydroxamate inhibitors for thermolysinBioorganic & Medicinal Chemistry Letters, 1998
- Effects of MDL 100,240, a Dual Inhibitor of Angiotensin-Converting Enzyme and Neutral Endopeptidase on the Vasopressor Response to Exogenous Angiotensin I and Angiotensin II Challenges in Healthy VolunteersJournal of Cardiovascular Pharmacology, 1998
- Effects of Omapatrilat in Low, Normal, and High Renin Experimental HypertensionAmerican Journal of Hypertension, 1998
- Dual Metalloprotease Inhibitors: Mercaptoacetyl-Based Fused Heterocyclic Dipeptide Mimetics as Inhibitors of Angiotensin-Converting Enzyme and Neutral EndopeptidaseJournal of Medicinal Chemistry, 1997
- Dual inhibition of angiotensin converting enzyme and neutral endopeptidase 24.11Published by Elsevier ,1997
- Section Review: Cardiovascular & Renal: Recent advances in the development of dual angiotensin-converting enzyme and neutral endopeptidase inhibitorsExpert Opinion on Therapeutic Patents, 1996
- Dual metalloprotease inhibitors. I. constrained peptidomimetics of mercaptoacyl dipeptidesBioorganic & Medicinal Chemistry Letters, 1994
- New bidentates as full inhibitors of enkephalin-degrading enzymes: synthesis and analgesic propertiesJournal of Medicinal Chemistry, 1985